查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1971337

医药级碳酸锂市场－全球产业规模、份额、趋势、机会、预测：依纯度、应用、地区和竞争格局划分，2021-2031年

Pharmaceutical Grade Lithium Carbonate Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Purity (99%, Above 99%), By Application (Extended Release, Immediate Release), By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球医药级碳酸锂市场预计将从 2025 年的 1.4591 亿美元成长到 2031 年的 1.8473 亿美元，复合年增长率为 4.01%。

这种高纯度无机化合物是一种重要的情绪稳定剂，主要用于治疗躁郁症和躁症发作。其市场基础在于全球精神疾病发病率的上升和精神卫生保健基础设施的扩张，这确保了对长期药物治疗的稳定需求。这些基本驱动因素赋予了市场稳定性，使其不受工业应用週期的影响，从而保护该行业免受其他化学工业中常见的市场波动。

市场概览
预测期 2027-2031
市场规模：2025年 1.4591亿美元
市场规模：2031年 1.8473亿美元
复合年增长率：2026-2031年 4.01%
成长最快的细分市场 缓释
最大的市场 北美洲

然而，来自电动车市场的激烈竞争给该行业带来了原材料供应的巨大挑战。对锂资源的竞争加剧了供应链的紧张，并使医疗提炼所需原料的采购变得更加复杂。根据美国地质调查局（USGS）预测，到2024年，电池产业将占全球锂消耗量的87%，而医疗产业仅占约1%。这种巨大的不平衡凸显了製药生产极易受到工业供不应求。

市场驱动因素

全球双极性情感障碍和情绪障碍发病率的不断上升是推动药用级碳酸锂市场发展的主要动力。高效情绪稳定剂的持续生产得益于精神疾病诊断准确性的提高、消除歧视的努力取得进展以及需要长期服药人群的显着增长。这形成了一个稳定的需求基础，与电池使用週期性的波动模式形成鲜明对比。主要医疗保健市场受影响人群的庞大规模清晰地印证了这一趋势。根据2024年10月发布的《2025年美国精神健康状况报告》，2024年美国成年人中将有23.40%患有精神疾病，这意味着一个庞大的群体可能需要精神科干预。

同时，儘管电池产业占据主导地位，但高纯度锂精炼和萃取技术的进步对于满足医疗需求至关重要。加工能力的提升使製造商能够有效地将药用级成分与工业级盐水分离，从而避免供应短缺阻碍基本药物的生产。这项业务扩张体现在公司近期的各项指标。根据Arcadium Lithium于2025年2月发布的“2024年第四季度及全年财务业绩”，第四季度总销售量（以碳酸锂当量计）较第三季度增长56%，表明产能有所提升。在市场波动的情况下，产能的扩张对于稳定医疗供应链至关重要。根据上海金属市场数据显示，2024年底电池用碳酸锂的平均现货价格为每吨75,050元人民币，这意味着在当前的价格环境下，高效的高纯度精炼技术在确保医药原料供应方面具有显着的竞争优势。

市场挑战

电动车 (EV) 产业对原料的激烈竞争，严重阻碍了全球医药级碳酸锂市场的扩张。随着汽车产业为实现脱碳目标而迅速扩大生产规模，其消耗了大部分可用的锂原料，为其他高纯度应用领域造成了严重的瓶颈。这种资源垄断扰乱了依赖严格监管的高等级碳酸锂的製药企业的供应链。大量原料被转移到电池製造领域，导致用于医用级纯化的前驱化合物供应不足，使製药企业面临供应不稳定和议价能力下降的困境。

资源配置的这种不平衡使得医疗保健产业极易受到大型工业企业筹资策略的影响。由于药品需求相对小规模，製造商往往难以从矿业公司获得优先采购名额，而矿业公司则倾向于优先签订电池产业特有的大型长期承购合约。近期行业统计数据凸显了这种不平衡的严重程度。根据国际锂协会预测，2024年全球锂需求量将达到约130万吨碳酸锂当量。这项庞大的消费需求主要由储能需求驱动，实际上已将医药市场边缘化，使得稳定采购关键原料变得越来越困难且高成本。

市场趋势

神经退化性疾病临床研究的拓展标誌着市场格局的重大变革，锂的效用也从传统的双极性情感疾患治疗扩展到其他领域。日益增长的失智症带来的经济和社会影响亟待缓解，这推动了对锂在阿兹海默症及其他疾病治疗中神经保护作用的研究不断深入。这项转变将大幅扩大药用级锂化合物的潜在患者群，并建立一条独立于精神科护理的全新长期需求管道。这些疾病带来的经济负担凸显了这个机会的重要性。根据阿兹海默症协会于2024年3月发布的《2024年阿兹海默症事实与数据》报告，预计到2024年，美国阿兹海默症及其他失智症患者的总照护费用将达到3,600亿美元，凸显了开发有效锂基治疗方法的巨大市场奖励。

同时，旨在缓解电池行业竞争的区域性供应链正在兴起，这正在改变筹资策略，以保护医疗库存免受行业短缺的影响。各国政府正在製定法律，设定国内加工目标，以确保包括製药在内的关键产业能够获得必要的矿产资源。这可以防止矿产资源完全被亚洲电池製造网路消耗。这一趋势迫使医用锂精炼商与不受全球出口不稳定影响的区域精炼厂合作。近年来，这项结构性变化已在关键政策框架中得到正式规定。欧盟于2024年5月发布的《基本原料法案》设定了一个具有约束力的目标，即到2030年，欧盟将在其区域内加工其战略原材料（包括锂）年消耗量的40%，旨在为高纯度应用建立强大的区域原材料基础。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：医药级碳酸锂的全球市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 依纯度等级（99%、99%或更高）
    • 依用途（缓释製剂、速释製剂）
    • 按地区
    • 按公司（2025 年）
  • 市场地图

第六章：北美药用级碳酸锂市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国别分析
    • 我们
    • 加拿大
    • 墨西哥

第七章：欧洲药用级碳酸锂市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国别分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区医药级碳酸锂市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国别分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东和非洲药用级碳酸锂市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东与非洲：国别分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章：南美洲药用级碳酸锂市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国别分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 促进因素
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 近期趋势

第十三章：全球药用级碳酸锂市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的议价能力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • Arcadium Lithium PLC
  • Albemarle Corporation
  • Jiangsu Lianhuan Pharmaceutical Co., Ltd.
  • American Elements Corp.
  • Jiangsu Nhwa Pharmaceutical Co., Ltd.
  • Panchsheel Organics Ltd
  • Blanver Farmoquimica e Farmaceutica SA

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 19577

The Global Pharmaceutical Grade Lithium Carbonate Market is projected to expand from USD 145.91 Million in 2025 to USD 184.73 Million by 2031, registering a CAGR of 4.01%. As a high-purity inorganic compound, this substance functions primarily as a vital mood stabilizer used to treat bipolar disorder and manic episodes. The market's foundation rests on the rising global incidence of mental health conditions and the broadening of psychiatric healthcare infrastructure, which guarantee steady demand for long-term pharmacological treatments. These fundamental drivers provide market stability that operates independently of industrial application cycles, protecting the sector from the volatility frequently observed in other chemical industries.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 145.91 Million
Market Size 2031USD 184.73 Million
CAGR 2026-20314.01%
Fastest Growing SegmentExtended Release
Largest MarketNorth America

However, the industry faces a substantial obstacle regarding raw material accessibility due to fierce competition from the electric vehicle market. This contest for lithium resources places stress on the supply chain and adds complexity to acquiring the feedstock necessary for medical purification. According to the U.S. Geological Survey, the medical sector represented roughly 1 percent of global lithium consumption in 2024, whereas the battery industry consumed 87 percent. This significant imbalance underscores how susceptible pharmaceutical production is to wider industrial supply deficits.

Market Driver

The increasing global incidence of bipolar and mood disorders serves as the main engine for the pharmaceutical grade lithium carbonate market, requiring continuous production of high-efficacy mood stabilizers. As mental health diagnoses become more accurate and destigmatization efforts grow, the population needing long-term pharmacological care has expanded substantially, establishing a stable demand base that contrasts with the cyclical patterns of battery usage. This trajectory is highlighted by the vast size of the affected demographic in key healthcare markets. According to Mental Health America's 'State of Mental Health in America 2025' report released in October 2025, 23.40 percent of adults in the United States experienced a mental illness in 2024, representing a massive group potentially requiring psychiatric intervention.

Concurrently, progress in high-purity lithium refining and extraction technologies is vital for enabling suppliers to satisfy medical requirements despite the dominance of the battery sector. Improved processing capabilities permit manufacturers to effectively isolate pharmaceutical-grade fractions from technical-grade brine, preventing supply limitations from hindering essential medication production. This operational expansion is evident in recent corporate metrics; according to Arcadium Lithium's 'Fourth Quarter and Full Year 2024 Results' from February 2025, total volumes sold in the fourth quarter rose by 56 percent on a Lithium Carbonate Equivalent basis compared to the third quarter, indicating enhanced output capacity. Such volume expansion is critical for stabilizing the medical supply chain amidst fluctuating market dynamics; according to the Shanghai Metal Market, the average spot price of battery-grade lithium carbonate settled at 75,050 yuan per metric ton by the end of 2024, suggesting a pricing landscape where efficient high-purity refining is a crucial competitive advantage for securing pharmaceutical feedstock.

Market Challenge

The intense competition for raw materials driven by the electric vehicle (EV) sector acts as a significant impediment to the expansion of the Global Pharmaceutical Grade Lithium Carbonate Market. As the automotive industry rapidly increases production to achieve decarbonization goals, it consumes the vast majority of available lithium feedstock, creating a critical bottleneck for other high-purity uses. This resource monopolization interferes with the supply chain for pharmaceutical producers, who depend on strictly regulated, high-grade lithium carbonate. The immense quantity of material redirected toward battery manufacturing restricts the availability of precursor compounds necessary for medical purification, compelling pharmaceutical firms to deal with supply instability and reduced negotiation leverage.

This disparity in resource allocation renders the medical sector extremely susceptible to the procurement tactics of major industrial entities. Since pharmaceutical demand involves comparatively lower volumes, manufacturers frequently struggle to obtain priority status from mining firms that prefer the massive, long-term offtake agreements characteristic of the battery sector. The scale of this inequality is highlighted by recent industrial figures. According to the International Lithium Association, global lithium demand hit roughly 1.3 million tonnes of lithium carbonate equivalent in 2024. This enormous consumption volume, spurred chiefly by energy storage requirements, effectively pushes the pharmaceutical market to the margins, making the reliable acquisition of essential raw materials an increasingly difficult and expensive undertaking.

Market Trends

The broadening of clinical research into neurodegenerative applications marks a pivotal evolution in the market, expanding lithium's utility beyond its conventional function in managing bipolar disorder. Studies are increasingly concentrating on lithium's neuroprotective capabilities for treating conditions like Alzheimer's disease, motivated by the pressing need to mitigate the growing economic and social impacts of dementia. This transition effectively enlarges the potential patient base for pharmaceutical-grade compounds, establishing a new long-term demand channel separate from psychiatric care. The significance of this opportunity is emphasized by the financial costs linked to these ailments; according to the Alzheimer's Association's '2024 Alzheimer's Disease Facts and Figures' report from March 2024, the total cost of care for individuals with Alzheimer's and other dementias in the United States was projected to hit $360 billion in 2024, underlining the substantial market incentive for developing effective lithium-based treatments.

At the same time, the rise of region-specific supply chains aimed at mitigating competition from the battery sector is transforming procurement strategies to safeguard medical inventory against industrial shortages. Governments are enacting legislation with domestic processing goals to guarantee that vital minerals remain accessible to critical sectors, including pharmaceuticals, rather than being wholly consumed by the Asian battery manufacturing network. This trend compels medical lithium purifiers to integrate with localized refining hubs that are shielded from global export instability. This structural shift is formalized in significant recent policy frameworks; according to the European Union's 'Critical Raw Materials Act' from May 2024, the legislation sets a binding target for the bloc to process 40 percent of its annual strategic raw material consumption, including lithium, domestically by 2030, thereby ensuring a robust regional feedstock foundation for high-purity applications.

Key Market Players

  • Arcadium Lithium PLC
  • Albemarle Corporation
  • Jiangsu Lianhuan Pharmaceutical Co., Ltd.
  • American Elements Corp.
  • Jiangsu Nhwa Pharmaceutical Co., Ltd.
  • Panchsheel Organics Ltd
  • Blanver Farmoquimica e Farmaceutica S.A.

Report Scope

In this report, the Global Pharmaceutical Grade Lithium Carbonate Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pharmaceutical Grade Lithium Carbonate Market, By Purity

  • 99%
  • Above 99%

Pharmaceutical Grade Lithium Carbonate Market, By Application

  • Extended Release
  • Immediate Release

Pharmaceutical Grade Lithium Carbonate Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Pharmaceutical Grade Lithium Carbonate Market.

Available Customizations:

Global Pharmaceutical Grade Lithium Carbonate Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Pharmaceutical Grade Lithium Carbonate Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Purity (99%, Above 99%)
    • 5.2.2. By Application (Extended Release, Immediate Release)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Pharmaceutical Grade Lithium Carbonate Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Purity
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Pharmaceutical Grade Lithium Carbonate Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Purity
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Pharmaceutical Grade Lithium Carbonate Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Purity
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Pharmaceutical Grade Lithium Carbonate Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Purity
        • 6.3.3.2.2. By Application

7. Europe Pharmaceutical Grade Lithium Carbonate Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Purity
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Pharmaceutical Grade Lithium Carbonate Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Purity
        • 7.3.1.2.2. By Application
    • 7.3.2. France Pharmaceutical Grade Lithium Carbonate Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Purity
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom Pharmaceutical Grade Lithium Carbonate Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Purity
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Pharmaceutical Grade Lithium Carbonate Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Purity
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Pharmaceutical Grade Lithium Carbonate Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Purity
        • 7.3.5.2.2. By Application

8. Asia Pacific Pharmaceutical Grade Lithium Carbonate Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Purity
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Pharmaceutical Grade Lithium Carbonate Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Purity
        • 8.3.1.2.2. By Application
    • 8.3.2. India Pharmaceutical Grade Lithium Carbonate Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Purity
        • 8.3.2.2.2. By Application
    • 8.3.3. Japan Pharmaceutical Grade Lithium Carbonate Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Purity
        • 8.3.3.2.2. By Application
    • 8.3.4. South Korea Pharmaceutical Grade Lithium Carbonate Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Purity
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Pharmaceutical Grade Lithium Carbonate Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Purity
        • 8.3.5.2.2. By Application

9. Middle East & Africa Pharmaceutical Grade Lithium Carbonate Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Purity
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Pharmaceutical Grade Lithium Carbonate Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Purity
        • 9.3.1.2.2. By Application
    • 9.3.2. UAE Pharmaceutical Grade Lithium Carbonate Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Purity
        • 9.3.2.2.2. By Application
    • 9.3.3. South Africa Pharmaceutical Grade Lithium Carbonate Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Purity
        • 9.3.3.2.2. By Application

10. South America Pharmaceutical Grade Lithium Carbonate Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Purity
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Pharmaceutical Grade Lithium Carbonate Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Purity
        • 10.3.1.2.2. By Application
    • 10.3.2. Colombia Pharmaceutical Grade Lithium Carbonate Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Purity
        • 10.3.2.2.2. By Application
    • 10.3.3. Argentina Pharmaceutical Grade Lithium Carbonate Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Purity
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Pharmaceutical Grade Lithium Carbonate Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Arcadium Lithium PLC
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Albemarle Corporation
  • 15.3. Jiangsu Lianhuan Pharmaceutical Co., Ltd.
  • 15.4. American Elements Corp.
  • 15.5. Jiangsu Nhwa Pharmaceutical Co., Ltd.
  • 15.6. Panchsheel Organics Ltd
  • 15.7. Blanver Farmoquimica e Farmaceutica S.A.

16. Strategic Recommendations

17. About Us & Disclaimer